3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
September's been a lousy month for biotech stocks with the Nasdaq Biotechnology Index down around 5.7% since the end of August. Rising interest rates are the main cause for concern, but that isn't a good reason to lose faith in this particular industry. You could sit around feeling sad about the September sell-off, or you could take advantage of some bargain stock opportunities.